TERI O'NEIL: Open Payments
NPI 1528241585 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 10 payments from 10 companies in 2025. Trend: 2023 $1,184 · 2024 $925 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $108 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $98 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| Neurocrine BioSciences, Inc. | 1 | $83 |
| Xeris Pharmaceuticals, Inc. | 1 | $83 |
| Sumitomo Pharma America, Inc. | 1 | $83 |
| Sage Therapeutics, LLC | 1 | $80 |
| COLOPLAST CORP | 1 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $73 |
Products named: INJECTAFER, AUSTEDO XR, VOQUEZNA, INGREZZA, GVOKE HYPOPEN, MYFEMBREE, Titan.
Industry payments across MD — which companies pay providers there.
